Edwards Foresees Percutaneous Heart Valve Replacement Milestones In 2006

Edwards Lifesciences expects to complete enrollment in the U.S. feasibility study for its Cribier-Edwards minimally invasive aortic heart valve during the first half of 2006

More from Archive

More from Medtech Insight